サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654713

世界のアシュワガンダサプリメント市場-2025-2032年

Global Ashwagandha Supplements Market - 2025-2032

出版日
ページ情報
英文 206 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
世界のアシュワガンダサプリメント市場-2025-2032年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 206 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のアシュワガンダサプリメント市場は2024年に7億2,026万米ドルに達し、2032年には1兆4,457億3,000万米ドルに達すると予測され、予測期間2025年のCAGRは9.10%で成長する見込みです。

アシュワガンダサプリメント市場は、ストレス管理、免疫力強化、一般的な健康のための天然素材やハーブを使ったソリューションに対する消費者の意識の高まりに後押しされ、大幅な拡大を経験しています。アシュワガンダサプリメントに関する規制の枠組みは地域によって異なります。米国では、FDAが栄養補助食品法（DSHEA）に基づき、アシュワガンダを栄養補助食品に分類しています。欧州ではEFSAが安全性と効能を管理しているが、インドのAYUSH省は品質と効能を保証するためにアーユルヴェーダ製品を管理しています。

ホリスティックな健康のために天然のアダプトゲンを優先するアーユルヴェーダやその他の伝統医学の人気が高まっていることは、この分野にとって重要なきっかけとなっています。ヴィーガン（完全菜食主義者）向けのアシュワガンダサプリメントが入手しやすくなっていることも、植物性食品を利用する人口の増加に対する市場の魅力を高めています。

市場の拡大には技術革新が不可欠であり、生産者は研究開発にリソースを割いて高力価のエキスやオーガニック製剤を生産しています。北米と欧州は、代替医療とハーブ療法に対する消費者の関心の高まりにより市場をリードしています。一方、アジア太平洋地域は、伝統的なアーユルヴェーダ療法におけるハーブの役割の定着に後押しされ、大幅な拡大を目の当たりにしています。

ダイナミクス

促進要因1-健康とウェルネスの動向

世界の健康とウェルネスの動向は、アシュワガンダのような天然ハーブサプリメント市場の主要な触媒として浮上しています。人々が予防ヘルスケアを重視し、ホリスティックなライフスタイルを採用するようになるにつれ、健康状態を改善するための自然療法への傾倒が高まっています。この動向は、健康的な食事が支持されている北米などで特に顕著です。

2024年9月に発表されたBusinessDasher社の最新レポートによると、アメリカ人の50％が健康的な食生活を維持しようと積極的に努力しており、62％が健康的であることを食品や飲飲料を選ぶ際の重要な基準としています。さらに、63％の米国人が購入前に食品加工の程度を評価しており、クリーンでオーガニックな製品への志向が高まっていることを示しています。

健康的な食生活を優先する人の56％がオーガニック商品を選んでおり、加工されていない自然な栄養素への移行が強調されています。精神的な健康を重視する傾向が強まり、リラックスを促し、ストレスを緩和し、精神的な幸福感を高める製品を求める消費者が増えていることが、この動向を後押ししています。アシュワガンダは、ストレスを緩和し認知機能を高める効能が認められており、身体的・精神的な健康を促進する商品に対する需要の高まりに対応し、健康・ウェルネス産業における重要な地位を確立しています。

促進要因2-新製品開発

アシュワガンダのサプリメント分野は、代替健康療法に対する消費者の欲求の高まりに後押しされ、大幅な拡大を経験しています。各ブランドは、従来のカプセルや粉末だけでなく、グミ、ドリンク、機能性ミールといった斬新な形態を取り入れるなど、製品の幅を急速に広げています。この変化は、日常生活に無理なく取り入れられる、シンプルで楽しい代替消費への志向の高まりに対応しています。

この多様化の一例として、オーガニック・インディアは2024年8月にアシュワガンダ・オーガニック・グミを発売しました。レモンライム風味のこのグミは、1個当たりKSM-66アシュワガンダ根エキスを300mg摂取でき、低糖質でオーガニック認定を受けた製剤で、ストレス緩和と免疫力向上のメリットをもたらします。この動きは、機能性とおいしさを兼ね備えたサプリメントを消費者が求めるという、より広範な動向を象徴しています。

ヘリテージフーズは2020年12月にアシュワガンダミルクを発売しました。このアーユルヴェーダにヒントを得たすぐに飲める製剤は、パンデミック後に重視される免疫力とウェルネスを活用したものです。2024年4月、英国市場は500mgのアシュワガンダ根飲料「Tranquilo」を発売しました。企業がアシュワガンダのアダプトジェニックな資質を利用して、ホリスティックなウェルネス・ソリューションに対する需要の高まりに対応するユニークな製品を開発していることから、市場の急速な進化は大きな成長の見通しを浮き彫りにしています。

阻害要因：標準化エキスの高コスト

標準化されたアシュワガンダ抽出物の生産に関連する費用の増加は、市場に大きな課題をもたらしています。一貫した効能、純度、品質には、高度な加工方法、厳格な試験、品質管理要件の揺るぎない遵守が必要です。これらの技術は、特に消費者や規制当局が科学的に検証された製品を必要とする地域において、エキスが治療効果の基準を満たすことを確認するために極めて重要です。

とはいえ、こうした重要な対策は生産コストの上昇を招き、それが価格の上昇として顧客に転嫁されることが多いです。価格に敏感な地域では、このことがアシュワガンダサプリメントの広範な採用を妨げる可能性があります。消費者は、標準化や品質保証の程度が同じでない、より経済的な選択肢を選ぶかもしれないからです。この問題は、裁量所得が制限され、高価な健康アイテムの費用が過大になる可能性のある開発途上国において特に適切です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 健康とウェルネスのトレンド
      • 新製品開発
    • 抑制要因
      • 標準化された抽出物の高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • DMIの見解

第6章 製品タイプ別

  • オーガニック
  • 従来タイプ

第7章 形態別

  • カプセル・タブレット
  • 粉末
  • 液体
  • グミ
  • その他

第8章 流通チャネル別

  • オンライン小売
  • スーパーマーケット・ハイパーマーケット
  • 直接販売
  • その他

第9章 用途別

  • ストレスと不安の管理
  • 認知の健康と記憶力の向上
  • エネルギーと持久力
  • 睡眠とリラクゼーション
  • 免疫の健康
  • その他

第10章 最終用途別

  • 成人
  • 高齢者
  • アスリート・フィットネス愛好家

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第13章 企業プロファイル

  • DSM
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • Sabinsa Corporation
  • Ingredion Incorporated
  • NutraScience Corporation
  • Himalaya Herbal Healthcare
  • Organic India
  • NOW Foods
  • Gaia Herbs
  • Nature's Way
  • KSM-66 Ashwagandha

第14章 付録

目次
Product Code: FB9137

Global Ashwagandha Supplements Market reached US$ 720.26 million in 2024 and is expected to reach US$ 1,445.73 billion by 2032, growing with a CAGR of 9.10% during the forecast period 2025-2032.

The Ashwagandha supplements market is experiencing significant expansion, driven by heightened consumer awareness of natural and herbal solutions for stress management, immunological enhancement and general wellness. The regulatory framework for ashwagandha supplements differs by area. In the US, the FDA categorizes ashwagandha as a dietary supplement in accordance with the Dietary Supplement Health and Education Act (DSHEA). In Europe, EFSA controls safety and claims, but India's AYUSH Ministry governs Ayurvedic products to guarantee quality and efficacy.

The increasing popularity of Ayurveda and other traditional medicine systems, which prioritize natural adaptogens for holistic health, is a significant catalyst for this sector. The increasing availability of vegan ashwagandha supplements has enhanced the market's attractiveness to the rising population of plant-based customers.

Innovation is essential for market expansion, as producers allocate resources to research and development to produce high-potency extracts and organic formulations. North America and Europe lead the market owing to a growing consumer interest in alternative health and herbal remedies. Meanwhile, the Asia-Pacific area is witnessing substantial expansion, bolstered by the herb's entrenched role in traditional Ayurvedic therapies.

Dynamics

Driver 1 - Health and wellness trend

The global health and wellness trend has emerged as a major catalyst for the market for natural and herbal supplements such as Ashwagandha. As people increasingly emphasize preventive healthcare and adopt holistic lifestyles, there is a rising inclination towards natural therapies to improve well-being. This trend is especially evident in areas such as North America, where healthy eating has gained traction.

A recent report by BusinessDasher, published in September 2024, indicates that 50% of Americans actively endeavor to maintain a healthy diet, while 62% regard healthfulness as a crucial criterion in their food and beverage shopping selections. Moreover, 63% of Americans assess the level of food processing before to purchase, indicating an increasing inclination towards clean and organic products.

Fifty-six percent of individuals prioritizing healthy eating select organic goods, highlighting the transition towards natural, unprocessed nutrients. The increased emphasis on mental health fuels this trend, as more consumers pursue products that facilitate relaxation, alleviate stress and enhance general mental well-being. Ashwagandha, recognized for its efficacy in alleviating stress and enhancing cognitive function, corresponds with the increasing demand for goods that promote both physical and mental well-being, establishing itself as a significant entity in the health and wellness industry.

Driver 2 - New product development

The Ashwagandha supplement sector is experiencing substantial expansion, propelled by increasing consumer desire for alternative health remedies. Brands are swiftly broadening their product ranges beyond conventional capsules and powders to incorporate novel formats such as gummies, drinks and functional meals. This transition corresponds with the increasing inclination towards simple and pleasurable consumption alternatives that effortlessly incorporate into everyday activities.

An instance of this diversification is Organic India, which launched Ashwagandha Organic Gummies in August 2024. These lemon-lime flavored gummies provide 300mg of KSM-66 Ashwagandha root extract per serving, delivering stress-relief and immunity-enhancing advantages in a low-sugar, certified organic formulation. This action represents a wider trend in which consumers pursue supplements that are both functional and tasty.

Heritage Foods launched Ashwagandha Milk in December 2020. This Ayurvedic-inspired, ready-to-consume formulation leverages the post-pandemic emphasis on immunity and wellness. In April 2024, the UK market introduced 'Tranquilo', a 500mg Ashwagandha Root beverage, targeting customers mindful of stress. The market's swift evolution highlights significant growth prospects, as firms utilize Ashwagandha's adaptogenic qualities to develop unique products that address the rising demand for holistic wellness solutions.

Restraint: High cost of standardized extracts

The increased expenses associated with the production of standardized Ashwagandha extracts create significant challenges for the market. Consistent potency, purity and quality necessitate sophisticated processing methods, stringent testing and unwavering compliance with quality control requirements. The techniques are crucial for confirming that the extract satisfies therapeutic efficacy standards, particularly in regions where consumers and regulatory authorities require scientifically validated products.

Nonetheless, these essential measures lead to elevated production expenses, which are frequently transferred to customers as increased prices. In price-sensitive areas, this may impede the extensive adoption of Ashwagandha supplements, as consumers might opt for more economical options that do not offer the same degree of standardization or quality assurance. This issue is especially pertinent in developing nations, where discretionary income is limited and the expense of premium health items might be excessive.

Segment Analysis

The global ashwagandha supplements market is segmented based on product type, form, distribution channel, application, end-user and region.

Harnessing the power of ashwagandha for stress and anxiety management

Ashwagandha supplements are recognized for being effective in managing stress and anxiety, mostly attributable to their adaptogenic characteristics. Extracts obtained from the plant's roots or a mixture of roots and leaves have been examined for their effects in lowering stress hormone levels, especially cortisol. Numerous clinical research indicate that patients who ingested ashwagandha for 6 to 8 weeks had significant decreases in stress, anxiety, exhaustion and sleep problems. The efficacy seems to be more significant at daily doses ranging from 500 to 600 mg.

Ashwagandha has shown encouraging outcomes in alleviating symptoms of depression and anxiety in particular demographics. A research of 66 patients with schizophrenia revealed that those who consumed 1,000 mg of ashwagandha extract daily for 12 weeks experienced more significant reductions in anxiety and despair than those receiving a placebo. Furthermore, studies suggest that ashwagandha may facilitate cognitive improvement in persons diagnosed with bipolar disorder.

Geographical Penetration

North America's growing interest in ashwagandha a natural solution for wellness

The North American Ashwagandha supplements market is witnessing substantial expansion, driven by increased awareness among consumers of botanical supplements and an escalating demand for natural therapies. With the rise of holistic wellness trends, Ashwagandha, a prominent adaptogen utilized in Ayurvedic treatment, is increasingly favored for stress management, mental health, sleep enhancement and overall well-being. Consumers are increasingly pursuing natural alternatives to traditional therapies, resulting in heightened demand for Ashwagandha extracts in dietary supplements.

The market's growth is moreover supported by the rising acknowledgment of adaptogens, including Ashwagandha, which assist the body in managing stress. The Food and Drug Administration (FDA) in the United States regulates Ashwagandha supplements under the Dietary Supplement Health and Education Act (DSHEA), mandating that manufacturers comply with good manufacturing practices (GMP) and precise labeling standards to uphold consumer trust and product quality.

Competitive Landscape

The major Global players in the market include DSM, Sabinsa Corporation, Ingredion Incorporated, NutraScience Corporation, Himalaya Herbal Healthcare organic India, NOW Foods, Gaia Herbs, Nature's Way and KSM-66 Ashwagandha.

By Product Type

  • Organic Ashwagandha Supplements
  • Conventional Ashwagandha Supplements

By Form

  • Capsules & Tablets
  • Powder
  • Liquid Extract
  • Gummies
  • Others

By Distribution Channel

  • Online Retail
  • Supermarkets & Hypermarkets
  • Direct Sales
  • Others

By Application

  • Stress & Anxiety Management
  • Cognitive Health & Memory Enhancement
  • Energy & Endurance
  • Sleep & Relaxation
  • Immune Health
  • Others

By End-User

  • Adults
  • Geriatric Population
  • Athletes & Fitness Enthusiasts

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In May 2024, Herbochem introduced +91 ASHWAGANDHA components suitable for the production of capsules, tablets, gummies or other preferred forms.
  • In August 2022, Swanson introduced Passion Fruit Orange Ashwagandha Gummies including Vitamin D to assist in stress management. This strategy facilitated the company's expansion of its product portfolio and market share.

Why Purchase the Report?

  • To visualize the global ashwagandha supplements market segmentation based on product type, form, distribution channel, application, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the ashwagandha supplements market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global ashwagandha supplements market report would provide approximately 78 tables, 77 figures and 206 pages.

Target Audience 2025

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet By Product Type
  • 3.2. Snippet By Form
  • 3.3. Snippet By Distribution Channel
  • 3.4. Snippet By Application
  • 3.5. Snippet By End-User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Health and wellness trend
      • 4.1.1.2. New product development
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of standardized extracts
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Organic Ashwagandha Supplements*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Conventional Ashwagandha Supplements

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Capsules & Tablets*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Powder
  • 7.4. Liquid Extract
  • 7.5. Gummies
  • 7.6. Others

8. By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 8.1.2. Market Attractiveness Index, By Distribution Channel
  • 8.2. Online Retail*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Supermarkets & Hypermarkets
  • 8.4. Direct Sales
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Stress & Anxiety Management*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Cognitive Health & Memory Enhancement
  • 9.4. Energy & Endurance
  • 9.5. Sleep & Relaxation
  • 9.6. Immune Health
  • 9.7. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Adults*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Geriatric Population
  • 10.4. Athletes & Fitness Enthusiasts

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. US
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. UK
      • 11.3.8.3. France
      • 11.3.8.4. Italy
      • 11.3.8.5. Spain
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. Australia
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. DSM*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Sabinsa Corporation
  • 13.3. Ingredion Incorporated
  • 13.4. NutraScience Corporation
  • 13.5. Himalaya Herbal Healthcare
  • 13.6. Organic India
  • 13.7. NOW Foods
  • 13.8. Gaia Herbs
  • 13.9. Nature's Way
  • 13.10. KSM-66 Ashwagandha

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us